Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 479157, 7 pages
http://dx.doi.org/10.1155/2015/479157
Research Article

Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol

Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China

Received 24 August 2015; Revised 16 November 2015; Accepted 23 November 2015

Academic Editor: Youngah Jo

Copyright © 2015 Min Yi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. W. Lam and D. LeRoith, “The worldwide diabetes epidemic,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 2, pp. 93–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Shi and F. B. Hu, “The global implications of diabetes and cancer,” The Lancet, vol. 383, no. 9933, pp. 1947–1948, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Yi, J.-S. Park, and D. A. Melton, “Betatrophin: a hormone that controls pancreatic β cell proliferation,” Cell, vol. 153, no. 4, pp. 747–758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Gusarova, C. A. Alexa, E. Na et al., “ANGPTL8/betatrophin does not control pancreatic beta cell expansion,” Cell, vol. 159, no. 3, pp. 691–696, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. K. H. Kaestner, “Betatrophin—promises fading and lessons learned,” Cell Metabolism, vol. 20, no. 6, pp. 932–933, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Jiao, J. Le Lay, M. Yu, A. Naji, and K. H. Kaestner, “Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting,” Diabetes, vol. 63, no. 4, pp. 1283–1288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Espes, M. Martinell, and P.-O. Carlsson, “Increased circulating betatrophin concentrations in patients with type 2 diabetes,” International Journal of Endocrinology, vol. 2014, Article ID 323407, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Espes, J. Lau, and P.-O. Carlsson, “Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes,” Diabetologia, vol. 57, no. 1, pp. 50–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Fu, F. Berhane, A. Fite, B. Seyoum, A. B. Abou-Samra, and R. Zhang, “Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity,” Scientific Reports, vol. 4, article 5013, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Hu, W. Sun, S. Yu et al., “Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients,” Diabetes Care, vol. 37, no. 10, pp. 2718–2722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Gómez-Ambrosi, E. Pascual, V. Catalán et al., “Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. E2004–E2009, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Guo, J. Lu, H. Yu et al., “Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals,” Obesity, vol. 23, no. 4, pp. 793–797, 2015. View at Publisher · View at Google Scholar
  13. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar · View at Scopus
  14. L. U. Monzillo and O. Hamdy, “Evaluation of insulin sensitivity in clinical practice and in research settings,” Nutrition Reviews, vol. 61, no. 12, pp. 397–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Chen, S. Chen, P. Huang et al., “In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats,” Diabetologia, vol. 58, no. 5, pp. 1036–1044, 2015. View at Publisher · View at Google Scholar
  17. X. Chen, P. Lu, W. He et al., “Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 1, pp. E96–E100, 2014. View at Publisher · View at Google Scholar
  18. A. Fenzl, B. K. Itariu, L. Kosi et al., “Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals,” Diabetologia, vol. 57, no. 6, pp. 1204–1208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Wu, H. Gao, Y. Ma, L. Fu, C. Zhang, and X. Luo, “Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance,” Pediatric Diabetes, 2014. View at Publisher · View at Google Scholar
  20. H. Yamada, T. Saito, A. Aoki et al., “Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes,” Endocrine Journal, vol. 62, no. 5, pp. 417–421, 2015. View at Publisher · View at Google Scholar
  21. M. Abu-Farha, J. Abubaker, I. Al-Khairi et al., “Higher plasma betatrophin/ANGPTL8 level in type 2 diabetes subjects does not correlate with blood glucose or insulin resistance,” Scientific Reports, vol. 5, Article ID 10949, 2015. View at Publisher · View at Google Scholar
  22. G. Ren, J. Y. Kim, and C. M. Smas, “Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism,” American Journal of Physiology—Endocrinology and Metabolism, vol. 303, no. 3, pp. E334–E351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Zhang, “Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels,” Biochemical and Biophysical Research Communications, vol. 424, no. 4, pp. 786–792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Fu, A. B. Abou-Samra, and R. Zhang, “An explanation for recent discrepancies in levels of human circulating betatrophin,” Diabetologia, vol. 57, pp. 2232–2234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Quagliarini, Y. Wang, J. Kozlitina et al., “Atypical angiopoietin-like protein that regulates ANGPTL3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 48, pp. 19751–19756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Zhang and A. B. Abou-Samra, “Emerging roles of Lipasin as a critical lipid regulator,” Biochemical and Biophysical Research Communications, vol. 432, no. 3, pp. 401–405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wang, F. Quagliarini, È. Gusaroèa et al., “Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 40, pp. 16109–16114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shimamura, M. Matsuda, H. Yasumo et al., “Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 2, pp. 366–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Lickert, “Betatrophin fuels beta cell proliferation: first step toward regenerative therapy,” Cell Metabolism, vol. 18, no. 1, pp. 5–6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Raghow, “Betatrophin: a liver-derived hormone for the pancreatic β-cell proliferation,” World Journal of Diabetes, vol. 4, no. 6, pp. 234–237, 2013. View at Publisher · View at Google Scholar
  31. P. Yi, J.-S. Park, and D. A. Melton, “Perspectives on the activities of ANGPTL8/Betatrophin,” Cell, vol. 159, no. 3, pp. 467–468, 2014. View at Publisher · View at Google Scholar · View at Scopus